By Ms. Akua B. BAAH Artificial Intelligence (AI) is rapidly reshaping the global healthcare landscape by improving diagnostics, optimizing treatment plans, and enhancing health system efficiency.
Pharma R&D faces rising trial complexity, high costs, and patient and investigator shortages, driving the need for adaptive models and data-driven strategies to speed therapies to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback